Why I Won’t Stop Buying Meta Before September This Year
Meta Platforms is gaining momentum in July 2026 as advertisers lean into AI-powered targeting. This piece explains wh...
Analyze when to tilt toward stocks or bonds in retirement. A practical guide to selecting the right index mix for your goals.
22,201 articlesMeta Platforms is gaining momentum in July 2026 as advertisers lean into AI-powered targeting. This piece explains wh...
NVIDIA’s latest results highlight a powerful software moat and growing AI infrastructure demand, underscoring why man...
A yearly reshuffle of Medicare Part D pharmacy networks can swing out-of-pocket costs for maintenance meds. Investors...
A stock surged 125% in 2026, turning heads across the market. This deep-dive breaks down the drivers of the move, how...
Copart director Daniel Englander recently sold 80,000 shares for about $2.2 million. With CPRT down roughly 40%, inve...
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
A seasoned investor’s eye looks beyond a single insider trade. This article breaks down why this limited insider sale...
A major stake from Nvidia lit a fire under Nebius Group, sending Nebius stock soared today. Here's what this means fo...
Oklo stock surged as investors weighed its plans for advanced reactors against the fast-moving AI data-center boom. T...
RPM International just posted a record Q4 EBIT across its segments. Alongside an insider Form 4 filing, this raises q...
Bitcoin has shed about half its value from October peaks, testing investor nerves. Retail buyers on Coinbase persist,...
Structure Therapeutics stock 187% gains over the last year drew attention from value seekers and momentum players ali...